Measured and Predicted Anterior Chamber Depth for Transscleral Suture-Fixated Posterior Chamber Intraocular Lenses

1993 ◽  
Vol 24 (1) ◽  
pp. 28-30
Author(s):  
Donna M Corder ◽  
Mark L McDermott ◽  
Dong H Shin ◽  
Kyle A Parrow ◽  
Laurie K Lau-Sickon
2021 ◽  
Vol 11 (1) ◽  
pp. 63-69
Author(s):  
Hongyun Wu ◽  
Liqun Hu

The purpose of this study was to examine visual function and eye structure before and after implantation of an intraocular lens in the phakic posterior chamber of the eye, for the correction of extreme myopia. Thirty subjects with 12∼ –27 diopters of extreme myopia were implanted with posterior chamber phakic intraocular lenses, and followed-up for 3–27 months. The follow-up examinations included uncorrected visual acuity (UCVA), best corrected visual acuity (BSCVA), intra ocular pressure (IOP), refractive power, lens transparency, intra ocular lens (IOL) position, endothelial cell density (ECD), anterior chamber depth (ACD), axial length, near point of accommodation, and macular retinal thickness. All indices improved after the surgery. These results demonstrate that the implantable collamer lens (ICL) for extreme myopia can effectively improve vision, and does not have negative effects on eye structure and accommodation.


2019 ◽  
Author(s):  
Daniel Röck ◽  
Karl Ulrich Bartz-Schmidt ◽  
Tobias Röck

Abstract Background This study aimed to investigate the incidence of and risk factors for the anterior chamber migration of an intravitreal dexamethasone implant (Ozurdex®). Methods A retrospective review of 640 consecutive intravitreal dexamethasone implant injections was conducted from February 2011 through February 2018 at the University Eye Hospital in Tübingen, Germany. Those patients who experienced anterior chamber dexamethasone implant migrations were identified, as well as the reasons for the anterior chamber migration. The surgical histories were obtained and comprehensive ophthalmic examinations were conducted for all of the eyes. Cross-tabulations, chi-squared tests, and Fisher's exact tests were used to assess the influences of different factors on the anterior chamber implant migrations. Results Overall, 4 eyes of four patients (0.63%) showed anterior chamber implant migrations. All four of the eyes were pseudophakic, and they had undergone prior vitrectomies. Three eyes had sclerally-fixated intraocular lenses, and one eye had a posterior chamber intraocular lens in the capsular bag, with a capsular tension ring due to partial zonular dehiscence. When comparing the vitrectomized eyes with reduced zonular/capsular bag complex integrity to the vitrectomized pseudophakic eyes with intact zonular/capsular bags, the former were significantly associated with an increased risk of anterior chamber implant migration (P = 0.008). The vitrectomized pseudophakic eyes, in contrast to the nonvitrectomized pseudophakic eyes, were significantly associated with an increased risk of anterior chamber implant migration (P = 0.009). Conclusions The anterior chamber migration of an intravitreal dexamethasone implant is a serious complication. To minimize the risk of permanent corneal edema, immediate removal of the implant with a 20-gauge alligator forceps over a 2.75-mm long clear corneal tunnel is important. Those patients with insufficient zonular support, defects, or missing posterior capsular membranes and vitrectomy histories present a high risk of anterior chamber dexamethasone implant migration.


2019 ◽  
Author(s):  
Daniel Röck ◽  
Karl Ulrich Bartz-Schmidt ◽  
Tobias Röck

Abstract Background This study aimed to investigate the incidence of and risk factors for the anterior chamber migration of an intravitreal dexamethasone implant (Ozurdex®). Methods A retrospective review of 640 consecutive intravitreal dexamethasone implant injections was conducted from February 2011 through February 2018 at the University Eye Hospital in Tübingen, Germany. Those patients who experienced anterior chamber dexamethasone implant migrations were identified, as well as the reasons for the anterior chamber migration. The surgical histories were obtained and comprehensive ophthalmic examinations were conducted for all of the eyes. Cross-tabulations, chi-squared tests, and Fisher's exact tests were used to assess the influences of different factors on the anterior chamber implant migrations. Results Overall, 4 eyes of four patients (0.63%) showed anterior chamber implant migrations. All four of the eyes were pseudophakic, and they had undergone prior vitrectomies. Three eyes had sclerally-fixated intraocular lenses, and one eye had a posterior chamber intraocular lens in the capsular bag, with a capsular tension ring due to partial zonular dehiscence. When comparing the vitrectomized eyes with reduced zonular/capsular bag complex integrity to the vitrectomized pseudophakic eyes with intact zonular/capsular bags, the former were significantly associated with an increased risk of anterior chamber implant migration (P = 0.008). The vitrectomized pseudophakic eyes, in contrast to the nonvitrectomized pseudophakic eyes, were significantly associated with an increased risk of anterior chamber implant migration (P = 0.009). Conclusions The anterior chamber migration of an intravitreal dexamethasone implant is a serious complication. To minimize the risk of permanent corneal edema, immediate removal of the implant with a 20-gauge alligator forceps over a 2.75-mm long clear corneal tunnel is important. Those patients with insufficient zonular support, defects, or missing posterior capsular membranes and vitrectomy histories present a high risk of anterior chamber dexamethasone implant migration.


2005 ◽  
Vol 31 (5) ◽  
pp. 903-909 ◽  
Author(s):  
Kendall E. Donaldson ◽  
Jason J. Gorscak ◽  
Donald L. Budenz ◽  
William J. Feuer ◽  
Matthew S. Benz ◽  
...  

Sign in / Sign up

Export Citation Format

Share Document